Found: 269
Select item for more details and to access through your institution.
Development and validation of diagnostic prediction model for solitary pulmonary nodules.
- Published in:
- Respirology, 2007, v. 12, n. 6, p. 856, doi. 10.1111/j.1440-1843.2007.01158.x
- By:
- Publication type:
- Article
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 6, p. 855, doi. 10.1007/s00428-023-03634-2
- By:
- Publication type:
- Article
Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 478, n. 6, p. 1161, doi. 10.1007/s00428-021-03017-5
- By:
- Publication type:
- Article
Characterization of a gene regulatory network underlying astringency loss in persimmon fruit.
- Published in:
- Planta: An International Journal of Plant Biology, 2018, v. 247, n. 3, p. 733, doi. 10.1007/s00425-017-2819-0
- By:
- Publication type:
- Article
Effects of seasonal temperature changes on DkMyb4 expression involved in proanthocyanidin regulation in two genotypes of persimmon ( Diospyros kaki Thunb.) fruit.
- Published in:
- Planta: An International Journal of Plant Biology, 2011, v. 233, n. 5, p. 883, doi. 10.1007/s00425-010-1346-z
- By:
- Publication type:
- Article
DkMyb2 wound-induced transcription factor of persimmon ( Diospyros kaki Thunb.), contributes to proanthocyanidin regulation.
- Published in:
- Planta: An International Journal of Plant Biology, 2010, v. 232, n. 5, p. 1045, doi. 10.1007/s00425-010-1241-7
- By:
- Publication type:
- Article
Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 7, p. 1737, doi. 10.1007/s00432-022-03932-3
- By:
- Publication type:
- Article
Treatment strategies for recurrent ovarian cancer in older adult patients in Japan: a study based on real-world data.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 5, p. 1335, doi. 10.1007/s00432-020-03168-z
- By:
- Publication type:
- Article
Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 7, p. 1249, doi. 10.1007/s00432-012-1199-x
- By:
- Publication type:
- Article
Second-line chemotherapy in patients with primary unknown cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 8, p. 1185, doi. 10.1007/s00432-011-0983-3
- By:
- Publication type:
- Article
Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 4, p. 551, doi. 10.1007/s00432-008-0488-x
- By:
- Publication type:
- Article
Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 11, p. 1199, doi. 10.1007/s00432-008-0401-7
- By:
- Publication type:
- Article
Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 3, p. 389, doi. 10.1007/s00432-007-0295-9
- By:
- Publication type:
- Article
Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2006, v. 132, n. 10, p. 635, doi. 10.1007/s00432-006-0110-z
- By:
- Publication type:
- Article
Cytoreductive robot‐assisted prostatectomy for systemic prostate rhabdomyosarcoma presenting as urinary retention.
- Published in:
- IJU Case Reports, 2022, v. 5, n. 2, p. 122, doi. 10.1002/iju5.12411
- By:
- Publication type:
- Article
Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation.
- Published in:
- Case Reports in Oncological Medicine, 2020, p. 1, doi. 10.1155/2020/2518383
- By:
- Publication type:
- Article
Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 917, doi. 10.1093/jjco/hyae051
- By:
- Publication type:
- Article
Genetic characteristics of platinum-sensitive ovarian clear cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 781, doi. 10.1093/jjco/hyad045
- By:
- Publication type:
- Article
A new era of the Asian clinical research network: a report from the ATLAS international symposium.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 619, doi. 10.1093/jjco/hyad033
- By:
- Publication type:
- Article
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 604, doi. 10.1093/jjco/hyad031
- By:
- Publication type:
- Article
Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 6, p. 494, doi. 10.1093/jjco/hyad021
- By:
- Publication type:
- Article
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 4, doi. 10.1093/jjco/hyac166
- By:
- Publication type:
- Article
Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1757, doi. 10.1093/jjco/hyab159
- By:
- Publication type:
- Article
The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 693, doi. 10.1093/jjco/hyab013
- By:
- Publication type:
- Article
Erratum to: Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1484, doi. 10.1093/jjco/hyaa227
- By:
- Publication type:
- Article
Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 1, p. 66, doi. 10.1093/jjco/hyz138
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 1, p. 12, doi. 10.1093/jjco/hyu160
- By:
- Publication type:
- Article
Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 287, doi. 10.1007/s10549-022-06787-x
- By:
- Publication type:
- Article
BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 323, doi. 10.1007/s10549-020-05647-w
- By:
- Publication type:
- Article
Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Utility of self-rated adherence for monitoring dietary and physical activity compliance and assessment of participant feedback of the Healthy Diet and Lifestyle Study pilot.
- Published in:
- Pilot & Feasibility Studies, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40814-021-00786-3
- By:
- Publication type:
- Article
Coronary ostium occlusion by coronary cusp displacement in Williams syndrome.
- Published in:
- Pediatrics International, 2016, v. 58, n. 6, p. 487, doi. 10.1111/ped.12828
- By:
- Publication type:
- Article
Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.
- Published in:
- Diabetes, Obesity & Metabolism, 2005, v. 7, n. 5, p. 517, doi. 10.1111/j.1463-1326.2004.00419.x
- By:
- Publication type:
- Article
Effects of peroxisome proliferator-activated receptor-α and -γ agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
- Published in:
- British Journal of Pharmacology, 2000, v. 130, n. 3, p. 495, doi. 10.1038/sj.bjp.0703328
- By:
- Publication type:
- Article
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
- Published in:
- British Journal of Pharmacology, 1999, v. 126, n. 7, p. 1674, doi. 10.1038/sj.bjp.0702481
- By:
- Publication type:
- Article
Contrasting Prognostic Implications of Platelet-Derived Growth Factor Receptor-β and Vascular Endothelial Growth Factor Receptor-2 in Patients with Angiosarcoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 10, p. 2841, doi. 10.1245/s10434-011-1640-4
- By:
- Publication type:
- Article
Can oncologists predict survival for patients with progressive disease after standard chemotherapies?
- Published in:
- Current Oncology, 2014, v. 21, n. 2, p. 84, doi. 10.3747/co.21.1743
- By:
- Publication type:
- Article
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Image‐guided percutaneous needle biopsy for the diagnosis of cancer of unknown primary.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 5, p. e479, doi. 10.1111/ajco.13762
- By:
- Publication type:
- Article
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 1, p. 173, doi. 10.1007/s10637-022-01321-8
- By:
- Publication type:
- Article
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 1, p. 1, doi. 10.1007/s10637-022-01307-6
- By:
- Publication type:
- Article
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1021, doi. 10.1007/s10637-022-01287-7
- By:
- Publication type:
- Article
Practical consideration for successful sequential tumor biopsies in first-in-human trials.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 4, p. 841, doi. 10.1007/s10637-022-01236-4
- By:
- Publication type:
- Article
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1559, doi. 10.1007/s10637-021-01107-4
- By:
- Publication type:
- Article
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1036, doi. 10.1007/s10637-020-01055-5
- By:
- Publication type:
- Article
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 152, doi. 10.1007/s10637-020-00942-1
- By:
- Publication type:
- Article